Literature DB >> 7948812

Helicobacter pylori prevalence in endoscopy and medical staff.

S K Lin1, J R Lambert, M A Schembri, L Nicholson, M G Korman.   

Abstract

The epidemiology and mode of transmission of Helicobacter pylori is currently unclear; it is postulated that the human stomach is the natural reservoir and that spread occurs by faecal-oral or oral-oral transmission. The aim of this study was to assess the prevalence of H. pylori in gastroenterologists and gastroenterology nurses compared with internists, general nurses and the normal population. An enzyme-linked immunosorbent assay technique (sensitivity 96%, specificity 88%) was used to detect circulating H. pylori immunoglobulin G antibodies in 39 gastroenterologists, 107 gastroenterology nurses, 25 internists and 42 general nurses. These subjects were compared to an age- and sex-matched Caucasian population obtained by random sampling of an urban population area. The overall prevalence of H. pylori in gastroenterologists was 69% compared to 40% of internists (P < 0.01), 17% of gastroenterology nurses (P < 0.001), 19% of general nurses (P < 0.01) and 32% of controls (P < 0.01). There was no significant difference in H. pylori prevalence between the gastroenterology nurses and controls, general nurses and controls. The prevalence in gastroenterologists increased with years of practice to levels greater than age-matched controls. The prevalence in gastroenterology nurses increased with age and years of working and was similar to age-matched control subjects. These findings of an increased prevalence of H. pylori infection in gastroenterologists performing endoscopy support human-to-human transmission possibly from patients to medical staff.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7948812     DOI: 10.1111/j.1440-1746.1994.tb01249.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  12 in total

1.  Protective measures may help prevent Helicobacter pylori infection.

Authors:  P Noone ; E R Waclawski
Journal:  BMJ       Date:  2001-01-20

Review 2.  Current issues in endoscope reprocessing and infection control during gastrointestinal endoscopy.

Authors:  Douglas B Nelson; Lawrence F Muscarella
Journal:  World J Gastroenterol       Date:  2006-07-07       Impact factor: 5.742

Review 3.  The occupational risk of Helicobacter pylori infection: a systematic review.

Authors:  Hassan Kheyre; Samantha Morais; Ana Ferro; Ana Rute Costa; Pedro Norton; Nuno Lunet; Bárbara Peleteiro
Journal:  Int Arch Occup Environ Health       Date:  2018-05-29       Impact factor: 3.015

4.  High seroprevalence of IgG against Helicobacter pylori among endoscopists in Taiwan.

Authors:  Y C Su; W M Wang; L T Chen; W Chiang; C Y Chen; S N Lu; C M Jan
Journal:  Dig Dis Sci       Date:  1996-08       Impact factor: 3.199

Review 5.  Transmission of Helicobacter pylori.

Authors:  M A Stone
Journal:  Postgrad Med J       Date:  1999-04       Impact factor: 2.401

6.  Seroprevalence of H. pylori infection and symptoms of upper gastrointestinal tract disease in two groups of health-care workers.

Authors:  Terence L Angtuaco; Virender K Sharma; Fred A Corder; Jean-Pierre Raufman; Colin W Howden
Journal:  Dig Dis Sci       Date:  2002-02       Impact factor: 3.199

7.  Epidemiology of Helicobacter pylori in Australia: a scoping review.

Authors:  Jillian Congedi; Craig Williams; Katherine L Baldock
Journal:  PeerJ       Date:  2022-05-31       Impact factor: 3.061

8.  Helicobacter pylori: a poor man's gut pathogen?

Authors:  Mohammed Mahdy Khalifa; Radwa Raed Sharaf; Ramy Karam Aziz
Journal:  Gut Pathog       Date:  2010-03-31       Impact factor: 4.181

Review 9.  Helicobacter pylori in intensive care: why we should be interested.

Authors:  Megan S Robertson; Robert L Clancy; John F Cade
Journal:  Intensive Care Med       Date:  2003-08-28       Impact factor: 17.440

10.  The occupational risk of Helicobacter pylori infection among gastroenterologists and their assistants.

Authors:  Claudia Peters; Anja Schablon; Melanie Harling; Claudia Wohlert; José Torres Costa; Albert Nienhaus
Journal:  BMC Infect Dis       Date:  2011-05-31       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.